CEFIC Appoints Frans Stokman as Executive Director of Petrochemicals Europe

The European Chemical Industry Council (CEFIC) has appointed Frans Stokman as new Executive Director of its industry sector Petrochemicals Europe, effective immediately.

CEFIC has appointed Frans Stokman as new Executive Director of its industry...
CEFIC has appointed Frans Stokman as new Executive Director of its industry sector Petrochemicals Europe. Source: CEFIC

Stokman has extensive experience in the global oil, gas and petrochemical industry. Before joining CEFIC, he worked for over 25 years for Shell, where he has held a broad range of global senior management positions. He is particularly experienced in helping companies or businesses manage change, transition or overcome a crisis.

“I am honored to have been chosen to take up the position of Petrochemicals Europe’s Executive Director. This is an unprecedented time to join CEFIC and especially its petrochemicals department. Our industry is playing a crucial role in helping governments, other industrial sectors and communities by supplying products that are essential in daily life and even more so in these times of crisis. Part of my job will be to ensure that the right EU framework is in place for the industry to continue to do so and to facilitate its role in the green recovery. I am convinced that the European petrochemicals industry has a major contribution to make in the transition to a more sustainable economy,” Stokman said.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read